Matt Marcos is a Senior Director with Alvarez & Marsal Healthcare Industry Group in New York. Mr. Marcos brings more than 14 years of diverse transactional, analytical and operating experience within the healthcare and chemicals industries. Mr. Marcos’ most notable assignments have included advising on a variety of sell-side, buy-side and leveraged buyouts across several sectors, including healthcare IT, revenue cycle management, medicare advantage, skilled-nursing, long-term care and pharmaceuticals. Mr. Marcos also served as adviser to the unsecured creditors committee for Integrated Health Services, Inc. and was part of the team advising the Board of Directors of Advanced Tissue Sciences during its Chapter 11 reorganization. Mr. Marcos’ domestic and cross-border transactional experience includes mergers, acquisitions, public equity, private equity, leveraged and management buyouts, strategic alliances and restructurings.
Prior to joining A&M, Mr. Marcos was a director with the healthcare investment banking group of CIT, and an executive director with Eureka Capital Markets, where he provided financial advisory services to public and private middle-market companies on valuations, mergers, acquisitions and private placements of both debt and equity. Prior to his investment banking career, he was a manager with the commodity chemicals division of Mitsubishi International Corporation in New York.
Mr. Marcos earned a bachelor’s degree in international affairs, with a minor in biology, from George Washington University and a master’s degree in business administration in finance from New York University, Stern School of Business. He has also completed studies at Universidad Antonio de Nebrija (Nebrisensis) in Madrid and was a licensed NASD General Securities Registered Representative (Series 7 and 63).